Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Users Online: 469 | Home Print this page Email this page Small font size Default font size Increase font size
ORAL PRESENTATION
Year : 2012  |  Volume : 32  |  Issue : 5  |  Page : 21

OA01.21. Nephro-protective activity of varunadi loha - An experimental study


Department of Rasashastra and Bhaishajya kalpana, National Institute of Ayurveda, Amer road, Jaipur - 302002, Rajasthan, India

Correspondence Address:
B Santhosh
Department of Rasashastra and Bhaishajya kalpana, National Institute of Ayurveda, Amer road, Jaipur - 302002, Rajasthan
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Purpose: It is a known fact that Iron is nephrotoxic, causing various urinary diseases which when untreated results in fatal condition like renal failure. But Ayurveda, after subjecting to various Samskaras (processings), has used Loha (Iron) in bhasma (calx) form in numerous formulations to treat urinary diseases. These diagonally opposite perceptions form the very base of the present work where in Varunadi loha, a formulation containing Loha bhasma, described in Bhaishjyaratnavali was studied for its pharmacological action using Sprague Dawley rats as an experimental model. The study was carried out at National Toxicology Center (NTC), Pune (IAEC Clearance no.-RP 128-181211). Method: The acute toxicity study showed Varunadi loha to be safe at the maximum dose of 2000mg/kg. Gentamycin induced nephrotoxicity model was used for the study. In the pilot study of 15 days, it was noted that rats in the prophylactic group died at the end of 8th day. So in the main study, prophylactic group was omitted. The main study was carried out with 24 rats which were equally divided in 4 groups as normal control, disease control, curative and safety. Result: In control group the results were not significant as the rats were non diseased and kept on normal diet. In disease control group, results were highly significant in serum creatinine and serum urea levels as the levels were raised. In curative group results were significant in serum levels as there was moderate decrease in serum creatinine and serum urea levels after the treatment with Varunadi loha. In the safety group the results were non-significant indicating the drug showed no adverse reactions at therapeutic dose. Conclusion: Significant decrease in serum creatinine and serum urea in curative group was suggestive that the drug Varunadi loha was delivering its best to improve the lost kidney function.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1603    
    Printed27    
    Emailed0    
    PDF Downloaded63    
    Comments [Add]    

Recommend this journal